Filing Flows › Bionano Genomics (BNGO) › Who owns the stock
Who owns Bionano Genomics (BNGO) stock
33 funds reported Bionano Genomics (BNGO) shares in their latest 13F filings, worth $2.8M in all. The largest holder is Aigh Capital Management LLC ($1.8M). Last quarter 17 funds added to their stakes and 8 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Aigh Capital Management LLC | 1,165,000 | $1.8M | new | 2026-09-30 |
| Carret Asset Management, LLC | 135,545 | $211K | increase | 2026-09-30 |
| GSA Capital Partners LLP | 150,284 | $170K | decrease | 2026-06-30 |
| Vanguard Group | 82,307 | $126K | increase | 2025-12-31 |
| Geode Capital Management, LLC | 89,993 | $102K | decrease | 2026-06-30 |
| Vanguard Capital Management LLC | 82,388 | $93K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 51,578 | $58K | unchanged | 2026-06-30 |
| Renaissance Technologies LLC | 51,100 | $58K | increase | 2026-06-30 |
| Jane Street Group, LLC | 35,728 | $40K | new | 2026-06-30 |
| Prudential Financial | 31,600 | $36K | increase | 2026-06-30 |
| Northern Trust | 24,561 | $28K | increase | 2026-06-30 |
| XTX Topco | 16,295 | $18K | new | 2026-06-30 |
| Warberg Asset Management LLC | 10,000 | $16K | new | 2026-09-30 |
| Engineers Gate Manager LP | 11,988 | $14K | increase | 2026-06-30 |
| BlackRock | 9,937 | $11K | unchanged | 2026-06-30 |
Bionano Genomics' latest quarter
Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most BNGO stock?
By the latest 13F filings: Aigh Capital Management LLC ($1.8M); Carret Asset Management, LLC ($211K); GSA Capital Partners LLP ($170K); Vanguard Group ($126K); Geode Capital Management, LLC ($102K).
What is the short interest in BNGO?
1,360,054 shares were sold short at the 2026-10-15 settlement, -33.17% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.